Jérôme Cros

35PUBLICATIONS
126CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer cell biologyPaediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 03, 2026
Impact of Tumor Genomic Profile on Adjuvant Chemotherapy Efficacy in Resected Pancreatic Adenocarcinoma: Results From the PRODIGE-24/CCTG PA6 Study.

|Jul 27, 2026
Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.

|Apr 29, 2026
Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer.

|Apr 22, 2026
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer.

|Dec 19, 2025
Molecular alterations in high-grade neuroendocrine tumors of the small intestine.

Agathe Hercent, Julien Masliah-Planchon, David Cohen

|Dec 03, 2025
Chemoembolization using streptozotocin versus embolization in metastatic NETs.

Anne-Laure Védie, Francesco Matteini, Jérôme Cros

Pageof 6

Frequent Collaborators

10 joint publications

Remy Nicolle

7 joint publications

Louis de Mestier

5 joint publications

Jean-Baptiste Bachet

5 joint publications

Jean-François Emile